Marketing-authorisation holder · Canada
Aptalis Pharma Canada Ulc
13 medicines in 1 country, as authorisation holder.
Group structure
Other companies in the group
United States2
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
13 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BENTYLOL10 mg / 5 ml · Syrup | Dicycloverine | Canada | Cancelled | 1993 |
| BENTYLOL TABLET 10MG10 mg · Tablet | Dicycloverine | Canada | Cancelled | 1995 |
| BENTYLOL TABLET 20MG20 mg · Tablet | Dicycloverine | Canada | Cancelled | 1995 |
| CORTENEMA100 mg / 60 ml · Enema | Hydrocortisone | Canada | Cancelled | 1995 |
| MODULON200 mg · Tablet | Trimebutine | Canada | Cancelled | 1991 |
| PROCTOSEDYL5 mg + 10 mg + 10 mg + 5 mg · Suppository | Cinchocaine, Esculin, Framycetin, Hydrocortisone | Canada | Cancelled | 1997 |
| PROCTOSEDYL0.5 % + 1 % + 1 % + 0.5 % · Ointment | Cinchocaine, Esculin, Framycetin, Hydrocortisone | Canada | Cancelled | 2003 |
| ULTRASE20000 unit + 4500 unit + 25000 unit · Capsule (Enteric-Coated) | Amylase, Lipase, Protease | Canada | Cancelled | 1996 |
| ULTRESA88200 unit + 20700 unit + 80000 unit · Capsule (Delayed-Release) | Amylase, Lipase, Protease | Canada | Cancelled | |
| ULTRESA98000 unit + 23000 unit + 88900 unit · Capsule (Delayed-Release) | Amylase, Lipase, Protease | Canada | Cancelled | 1998 |
| ULTRESA58800 unit + 13800 unit + 53400 unit · Capsule (Delayed-Release) | Amylase, Lipase, Protease | Canada | Cancelled | 1998 |
| URSO250 mg · Tablet | Ursodeoxycholic acid | Canada | Cancelled | 1998 |
| URSO DS500 mg · Tablet | Ursodeoxycholic acid | Canada | Cancelled | 2003 |



